Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
Indica Labs expands digital pathology solutions in Asia Pacific
, /in Product News /by panglobalThe EURORealTime SARS-CoV-2 from EUROIMMUN is now validated for use with saliva as sample material as an alternative to throat swabs. Collection of saliva specimens is easier and less distressing for patients than taking nasal or throat swabs, especially for children.
HORIBA introduces compact haematology analysers with integrated ESR and CBC/DIFF
, /in Product News /by panglobalHORIBA has expanded its compact haematology instrument range with the launch of new models featuring on-board Erythrocyte Sedimentation Rate (ESR) testing. The Yumizen H550E (autoloader), H500E CT (closed tube), and H500E OT (open tube) now offer combined testing for CBC/DIFF with ESR results from whole blood in 60 seconds, enhancing their utility for inflammatory disease […]
Bio-Rad unveils enhanced Celselect Slides for improved CTC capture
, /in Product News /by panglobalBio-Rad Laboratories, has launched Celselect Slides 2.0, a significant upgrade to their technology for isolating circulating tumour cells (CTCs) from liquid biopsy samples. This latest iteration, compatible with Bio-Rad’s Genesis Cell Isolation System, offers substantial improvements in sample processing capacity and cell capture efficiency.
ELRIG UK and The Protein Society collaborate to advance protein sciences in drug discovery
, /in E-News, Therapeutic Drug Monitoring /by panglobalThe European Laboratory Research & Innovation Group (ELRIG) UK and The Protein Society (TPS) have announced a partnership aimed at advancing protein sciences in drug discovery. This collaboration will culminate in a joint conference, ‘Protein Sciences in Drug Discovery’, scheduled for 18-19 November 2024 in Cambridge, UK.
Sapio Sciences unveils partner programme to boost research and diagnostic capabilities
, /in E-News /by panglobalIn a move set to advance the lab informatics landscape, Sapio Sciences has launched its Partner Programme. This initiative aims to foster a robust ecosystem of technology vendors, service providers, and resellers, equipping them with essential resources to deliver cutting-edge solutions for scientists.
New collaboration aims to enhance colorectal cancer screening accuracy
, /in E-News, Tumour Markers /by panglobalA new partnership between Surfix Diagnostics, the Netherlands Cancer Institute (NKI), and CRCbioscreen will focus on the validation of novel biomarkers for colorectal cancer (CRC) screening. The collaboration, supported by a PPP grant from the TKI-program Life Sciences & Health of Health~Holland, aims to address the limitations of current screening methods and potentially revolutionise early […]
SciRhom raises €63 million to advance iRhom2-targeting therapies for autoimmune diseases
, /in Autoimmunity & Allergy, E-News /by panglobalMunich-based biopharmaceutical company SciRhom GmbH has secured a substantial €63 million (US$70 million) in Series A financing to accelerate the development of its pioneering iRhom2-targeting antibodies for autoimmune disorders. The oversubscribed funding round, co-led by Andera Partners, Kurma Partners, Hadean Ventures, MIG Capital, and Wellington Partners, will propel the company’s lead candidate toward clinical proof-of-concept […]
Newcells Biotech bolsters commercial team with key appointment
, /in E-News /by panglobalNewcastle-based drug discovery partner Newcells Biotech has appointed Emile Shaffu as Director of Sales. This strategic move aims to strengthen the company’s global market presence and enhance customer support in the field of in vitro models and bespoke assay services.
Cellular Origins acquires ACTIA Platform to enhance automated cell therapy production
, /in E-News, Molecular Diagnostics /by panglobalCellular Origins, a TTP company specialising in cell and gene therapy (CGT) manufacturing solutions, has announced the acquisition of the Autologous Cell Therapy Industrial Automation (ACTIA) Platform intellectual property. The acquisition is set to augment the company’s existing Constellation™ platform, which was launched in May 2023.
Together at the pulse of neurobiology
, /in Featured Articles, Autoimmunity & Allergy, Molecular Diagnostics, Rapid Tests & POC /by panglobalA unique portfolio of neurobiomarker tests The testing landscape for neurological diseases has expanded rapidly in recent years due to the characterisation of many novel biomarkers. With over 15 years of experience in neurological analytics, EUROIMMUN offers an unparalleled portfolio of assays for determination of more than 80 neurobiomarkers in autoimmune diseases, neurological infections and […]